This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biocon Biologics Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Ramprabu Nagarajan: Innovator in Insulin Purification
Introduction
Ramprabu Nagarajan is a notable inventor based in Karnataka, India. He has made significant contributions to the field of biotechnology, particularly in the purification of insulin analogues. His innovative work has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.
Latest Patents
Ramprabu Nagarajan holds a patent for a chromatography process aimed at the purification of insulin analogues. The patent, titled "Chromatography process for purification of insulin analogues," describes a method for purifying non-glycosylated insulin analogues from a mixture that includes both glycosylated and non-glycosylated proteins. This process effectively removes glycosylated proteins through a combination of two reverse-phase high-performance liquid chromatography (RP-HPLC) steps. He has 1 patent to his name.
Career Highlights
Nagarajan is currently employed at Biocon Biologics Limited, a leading biopharmaceutical company in India. His role involves research and development in the field of insulin production, where he applies his expertise to improve purification processes. His work is instrumental in advancing the quality and availability of insulin for patients worldwide.
Collaborations
Throughout his career, Ramprabu Nagarajan has collaborated with several professionals in the field. Notable coworkers include Minal Hashim and Azimoddin Minyasab Shaikh, who have contributed to various projects alongside him.
Conclusion
Ramprabu Nagarajan's innovative approach to insulin purification exemplifies the impact of dedicated research in biotechnology. His contributions are vital for improving diabetes treatment and enhancing patient care.